Astera Labs, Inc. (NASDAQ:ALAB – Get Free Report) has been assigned a consensus recommendation of “Buy” from the twelve analysts that are covering the firm, Marketbeat Ratings reports. Twelve investment analysts have rated the stock with a buy recommendation. The average 12-month price objective among brokerages that have issued a report on the stock in the last year is $94.67.
Several research firms recently weighed in on ALAB. Barclays upped their price target on Astera Labs from $70.00 to $87.00 and gave the company an “overweight” rating in a research report on Tuesday, November 5th. Morgan Stanley upped their price target on Astera Labs from $74.00 to $94.00 and gave the company an “overweight” rating in a research report on Tuesday, November 5th. Stifel Nicolaus upped their price target on Astera Labs from $80.00 to $100.00 and gave the company a “buy” rating in a research report on Tuesday, November 5th. Craig Hallum upped their price target on Astera Labs from $75.00 to $105.00 and gave the company a “buy” rating in a research report on Tuesday, November 5th. Finally, Needham & Company LLC reaffirmed a “buy” rating and issued a $65.00 target price on shares of Astera Labs in a research report on Wednesday, October 9th.
Get Our Latest Stock Analysis on ALAB
Insider Activity
Institutional Trading of Astera Labs
Several hedge funds have recently added to or reduced their stakes in the business. Avior Wealth Management LLC bought a new stake in shares of Astera Labs in the 3rd quarter worth approximately $361,000. Sei Investments Co. bought a new stake in shares of Astera Labs in the 1st quarter worth approximately $952,000. Meeder Asset Management Inc. bought a new stake in shares of Astera Labs in the 3rd quarter worth approximately $1,141,000. Bank of Hawaii bought a new stake in shares of Astera Labs in the 3rd quarter worth approximately $1,409,000. Finally, Vanguard Group Inc. bought a new stake in shares of Astera Labs in the 1st quarter worth approximately $127,268,000.
Astera Labs Stock Up 4.9 %
Shares of NASDAQ ALAB opened at $107.31 on Tuesday. Astera Labs has a 12 month low of $36.22 and a 12 month high of $113.85. The business has a fifty day simple moving average of $70.87 and a 200-day simple moving average of $60.05.
Astera Labs (NASDAQ:ALAB – Get Free Report) last posted its quarterly earnings results on Monday, November 4th. The company reported $0.23 earnings per share for the quarter, beating the consensus estimate of $0.17 by $0.06. The firm had revenue of $113.10 million for the quarter, compared to analyst estimates of $97.50 million. Astera Labs had a negative return on equity of 15.57% and a negative net margin of 30.69%. The firm’s revenue was up 47.1% compared to the same quarter last year. Equities research analysts forecast that Astera Labs will post -0.45 EPS for the current year.
About Astera Labs
Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.
Further Reading
- Five stocks we like better than Astera Labs
- Insider Buying Explained: What Investors Need to Know
- Abacus Life’s CEO on Cracking the Code of Longevity Returns
- ETF Screener: Uses and Step-by-Step Guide
- Elon Musk and Trump Push for Self-Driving Cars: 3 Stocks to Gain
- Dividend King Proctor & Gamble Is A Buy On Post-Earnings Weakness
- Discover the 3 Best Performing Stocks That Went Public in 2024
Receive News & Ratings for Astera Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astera Labs and related companies with MarketBeat.com's FREE daily email newsletter.